Navigation Links
NxStage Appoints Tom Shea as Senior Vice President of Manufacturing Operations
Date:3/31/2008

LAWRENCE, Mass., March 31 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Tom Shea has joined the Company as Senior Vice President of Manufacturing Operations, effective March 31, 2008. Mr. Shea will be responsible for all of NxStage's manufacturing operations, including the Company's five manufacturing facilities.

Mr. Shea joins NxStage with more than 20 years of operational management experience. Prior to joining NxStage, Mr. Shea held several leadership positions at Jabil Incorporated, a $12 billion Tier I contract manufacturer. Most recently, Mr. Shea served as Jabil's Global Business Unit Manager, supporting clients in the aerospace, defense and telecommunications industries. In this capacity, he developed operations, pricing and logistics strategies and implemented manufacturing plans that resulted in significant quarterly cost reductions. He previously served as Operations Manager at Jabil where he had full plant profit and loss responsibility for their Massachusetts facility.

"Tom comes from an industry built on aggressive cost management and I believe his experience working with regulated devices will be of tremendous benefit to NxStage," said Jeffrey H. Burbank, President & Chief Executive Officer of NxStage Medical. "Tom is a great fit for NxStage and we are extremely pleased to welcome him to the team."

Mr. Shea earned his M.B.A. at The University of Massachusetts and his B.S. in Production and Operations Management at Bryant University. He has completed the Operations Executive Leadership Program at Harvard University as well as Six Sigma Training.

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at http://www.nxstage.com.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Examples of these forward-looking statements include statements as to the contributions Mr. Shea will make to the Company's performance and operating results. All forward-looking statements involve risks, uncertainties and contingencies, many of which are beyond NxStage's control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance or achievements. Certain factors which may affect future operating results are detailed in NxStage's filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended December 31, 2007. In addition, the statements in this press release represent NxStage's expectations and beliefs as of the date of this press release. NxStage anticipates that subsequent events and developments may cause these expectations and beliefs to change. However, while NxStage may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so, whether as a result of new information, future events, or otherwise. These forward-looking statements should not be relied upon as representing NxStage's expectations or beliefs as of any date subsequent to the date of this press release.

Investor Relations Contact

Stephanie Marks for NxStage

1-888-698-6472

ir@nxstage.com


'/>"/>
SOURCE NxStage Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. NxStage Medical Announces Needle Supply Agreement with DaVita
2. NxStage Medical to Present at the Piper Jaffray Healthcare Conference on November 27, 2007
3. Arbios Announces SEPET(TM) Manufacturing Agreement With NxStage Medical
4. NxStage(R) Medical to Report Third Quarter 2007 Financial Results on Friday, November 2nd
5. NxStage Medical Provides Update on Medisystems Acquisition
6. NxStage Medical to Present at the Thomas Weisel Partners Healthcare Conference on September 5, 2007
7. ExonHit Appoints a New Management Board
8. Pharmasset Appoints Herbert J. Conrad as a Director
9. MacroChem Appoints David P. Luci as New CFO
10. Kosans Board of Directors Appoints Helen S. Kim as Chief Executive Officer
11. RainDance Appoints Becker Chief Commercial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... ... April 19, 2017 , ... ... financing round. This event adds to several other early achievements at ThermaGenix, including ... Scientific Teams. , ThermaGenix will use proceeds from the Series A-1 ...
(Date:4/19/2017)... and PUNE, India , April 19, 2017 /PRNewswire/ ... "Membrane Microfiltration Market: Global Opportunity Analysis and Industry Forecast, 2014-2022 ," the global ... $12,858 million by 2022, registering a CAGR of 9.6% from 2016 to 2022. ... ... ...
(Date:4/19/2017)... SOUTH SAN FRANCISCO, Calif. , April 19, ... VCYT ) today announced that it ... after close of market on Wednesday, May 3, 2017. ... call and webcast at 4:30 p.m. Eastern Time to discuss ... The live webcast and subsequent replay may ...
(Date:4/18/2017)... ... April 18, 2017 , ... ... awarded Channel Partners 2017 Next-Gen Solution Provider. , Channel Partners program recognizes IT ... with their vision, innovation, and advocacy of the channel during transition and convergence. ...
Breaking Biology Technology:
(Date:4/18/2017)... , April 18, 2017  Socionext Inc., a global expert ... a media edge server, the M820, which features the company,s hybrid ... software provided by Tera Probe, Inc., will be showcased during the ... the NAB show at the Las Vegas ... ...
(Date:4/11/2017)... Fla. , April 11, 2017 ... and secure authentication solutions, today announced that it ... Intelligence Advanced Research Projects Activity (IARPA) to develop ... Thor program. "Innovation has been a ... IARPA,s Thor program will allow us to innovate ...
(Date:4/6/2017)... 6, 2017 Forecasts by Product ... Readers, by End-Use (Transportation & Logistics, Government & Public ... & Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business ... Are you looking for a definitive report on ... ...
Breaking Biology News(10 mins):